Abstract
Study design: Retrospective analysis.
Objectives: To evaluate the efficacy of intrathecal baclofen (ITB) for upper extremity spastic hypertonia in tetraplegia of spinal origin.
Setting: University of Alabama at Birmingham hospital.
Methods: The medical records of 14 individuals with tetraplegia of spinal origin who underwent intrathecal baclofen pump placement were reviewed. The effects of intrathecal baclofen on spasm frequency, deep tendon reflexes, and tone (Ashworth scale) were assessed for the upper and lower extremities for a 1-year follow-up period.
Results: There were statistically significant declines in upper extremity spasm scores (1.8 points, P=0.012), reflex scores (1.4 points, P<0.0001) and Ashworth scores (0.6 points, P<0.0001) for the 1-year follow-up period. For the lower extremities, all decreases were significant (P<0.0001). There was also a statistically significant (P<0.0001) increase in intrathecal baclofen dosage requirements during the 1-year follow-up period to maintain the reductions in spasm frequency, reflexes and tone.
Conclusions: Intrathecal baclofen is a safe and effective intervention for treating upper extremity hypertonia of spinal origin. In addition, the level of intrathecal catheter placement is felt to be of importance.
Spinal Cord (2001) 39, 413–419.
Similar content being viewed by others
Article PDF
References
Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN . Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-yr experience Arch Phys Med Rehabil 1999 80: 13–19
Young RR, Delwaide PJ . Spasticity (part one of two parts) N Engl J Med 1981 304: 28–33
Young RR, Delwaide PJ . Spasticity (part two of two parts) N Engl J Med 1981 304: 96–99
Adams RD, Victor M (eds) . Principles of neurology. 5th edn McGraw-Hill, Inc.: New York 1993 p. 68
Meythaler JM et al. Continuous intrathecal baclofen in spinal cord spasticity: a prospective study Am J Phys Med Rehabil 1992 71: 321–327
Penn RD et al. Intrathecal baclofen for severe spinal spasticity N Engl J Med 1989 320: 1517–1522
Lazorthes Y et al. Chronic intrathecal baclofen administration for control of severe spasticity J Neurosurg 1990 72: 393–402
Coffey RJ, Cahill D, Steers W . Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study J Neurosurg 1999 78: 226–232
Meythaler JM et al. Intrathecal baclofen in hereditary spastic paraparesis Arch Phys Med Rehabil 1992 73: 794–797
Penn RD, Kroin JS . Long-term intrathecal baclofen infusion for treatment of spasticity J Neurosurg 1987 66: 181–185
Ordia JL, Fischer E, Adamski E, Spatz EL . Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity J Neurosurg 1996 85: 452–457
Ochs G et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study J Neurol Neurosurg Psychiatry 1989 52: 933–939
Loubser PG et al. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury Paraplegia 1991 29: 48–64
Broseta J et al. Use of intrathecal baclofen administered by programmable infusion pumps in resistant spasticity Acta Neurochir 1989 46: 39–45
Kroin JS, Penn RD . Cerebrospinal fluid pharmacokinectics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWF (eds). Parenteral drug therapy in spasticity and Parkinson's disease Canforth, United Kingdom: Pathenon Publishing 1991 pp 73–83
Hugenholtz H, Nelson RF, Dehoux E . Intrathecal baclofen – the importance of catheter position Can J Neurol Sci 1993 20: 165–167
Muller-Schwefe G, Penn RD . Physostigmine in the treatment of intrathecal baclofen overdose J Neurosurg 1989 71: 273–275
Grabb PA, Guin-Renfroe S, Meythaler JM . Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity Neurosurgery 1999 45: 833–837
Meythaler JM, DeVivo MJ, Hadley M . Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury Arch Phys Med Rehabil 1996 77: 461–466
Meythaler JM, Hadley M, McCrary A . Prospective study on the use of continuously infused intrathecal baclofen for spasticity due to acquired brain injury: A preliminary report J Neurosurg 1997 87: 415–419
Meythaler JM, Guin-Renfro S, Hadley M . Continuously infused intrathecal baclofen (ITB) for spastic-hypertonia in adult cerebral palsy [abstract] Am J Phys Med Rehabil 1998 77: 173
Sokol RR, Rohlf FJ Biometry San Francisco (CA): W.H. Freeman 1969
Ashworth B . Preliminary trial of carisoprodol in multiple sclerosis Practitioner 1964 192: 540–542
Lee KC, Carson L, Kinnin E, Patterson V . The Ashworth scale: a reliable and reproducible method of measuring spasticity J Neurol Rehabil 1989 3: 205–209
Meythaler JM, Guin-Renfroe, Hadley MN . Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report Am J Phys Med Rehabil 78: 247–254
Dressler D, Oeljeschlager RO, Ruther E . Severe tardive dystonia: treatment with continuous intrathecal baclofen administration Movement Disorders 1997 12: 585–587
Stayer C et al. Intrathecal baclofen therapy for stiffman syndrome and progressive encephalopathy with rigidity and myoclonus Neurology 1997 49: 1591–1597
Gilmartin R et al. Intrathecal baclofen for management of spastic cerebral palsy: a multicenter trial J Child Neurol 2000 15: 71–77
Van Schaeybroeck P et al. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study Neurosurgery 2000 46: 603–609
Albright AL et al. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy J Neurosurg 1998 88: 73–76
Armstrong RW et al. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin J Neurosurg 1997 87: 409–414
Engrand N, Guerot E, Rouamaba A . The efficacy of intrathecal baclofen in severe tetanus Anesthesiology 1999 90: 1773–1776
Akman MN et al. Intrathecal baclofen: does tolerance occur? Paraplegia 1993 31: 516–520
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burns, A., Meythaler, J. Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 39, 413–419 (2001). https://doi.org/10.1038/sj.sc.3101178
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.sc.3101178
Keywords
This article is cited by
-
Phenol neurolysis in people with spinal cord injury: a descriptive study
Spinal Cord Series and Cases (2022)
-
Plain radiography in patients treated with intrathecal drug delivery using an implantable pump device
Insights into Imaging (2017)
-
Long-lasting involuntary motor activity after spinal cord injury
Spinal Cord (2011)
-
Latest Approaches for the Treatment of Spasticity and Autonomic Dysreflexia in Chronic Spinal Cord Injury
Neurotherapeutics (2011)